We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Neonatal meningitis is a common cause of death and long-term disability among children, particularly in developing countries
The results of a scoping study on the fate and behaviour of oestrone seventeen oestradiol and ethinyl oestradiol in rivers.
The Medicines and Healthcare products Regulatory Agency (MHRA) is advising anyone experiencing skin redness or burning sensations after they have stopped using these creams or ointments to seek advice from their health professional before using these products again.
The Medicines and Healthcare products Regulatory Agency has today issued a recall asking patients to return affected products.
Online learning module on reducing the side effects of steroid medicines to help clinicians to optimise the use of corticosteroids.
Guidance on medicines for food and non-food horses and record keeping requirements including the horse passport.
Men who inject anabolic steroids and tanning drugs are at higher risk of HIV and viral hepatitis.
Risk of early psychiatric side-effects is one of several important safety issues for healthcare professionals to discuss with patients and carers, who should seek urgent medical advice in the event of any worrying symptoms.
It's illegal to drive if you're unfit to do so because you're on legal or illegal drugs, or you have certain levels of drugs or medicine in your blood
People who may have purchased Yiganerjing Cream are urged to discontinue use immediately as it contains an undisclosed steroid and two antifungal ingredients.
Rarely, severe adverse effects can occur on stopping treatment with topical corticosteroids, often after long-term continuous or inappropriate use of moderate to high potency products. To reduce the risks of these events, prescribe the topical corticosteroid of lowest potency needed...
Response to FOI 03-06-2011-144137-005.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).